CN1687783A - Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit - Google Patents
Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit Download PDFInfo
- Publication number
- CN1687783A CN1687783A CN 200510071059 CN200510071059A CN1687783A CN 1687783 A CN1687783 A CN 1687783A CN 200510071059 CN200510071059 CN 200510071059 CN 200510071059 A CN200510071059 A CN 200510071059A CN 1687783 A CN1687783 A CN 1687783A
- Authority
- CN
- China
- Prior art keywords
- rct
- antibody
- reagent
- enzyme
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 title claims abstract description 98
- 229940074095 ractopamine Drugs 0.000 title claims abstract description 97
- 230000036039 immunity Effects 0.000 title claims 2
- 238000010998 test method Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 claims abstract description 47
- 102000036639 antigens Human genes 0.000 claims abstract description 47
- 108091007433 antigens Proteins 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 32
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 108090000790 Enzymes Proteins 0.000 claims abstract description 31
- 238000002965 ELISA Methods 0.000 claims abstract description 24
- 230000003053 immunization Effects 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 89
- 239000000243 solution Substances 0.000 claims description 55
- 238000005406 washing Methods 0.000 claims description 25
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 20
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 14
- 229910019142 PO4 Inorganic materials 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 12
- 238000010168 coupling process Methods 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 12
- 239000010452 phosphate Substances 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- 239000003480 eluent Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 9
- 210000004408 hybridoma Anatomy 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 8
- 238000011534 incubation Methods 0.000 claims description 8
- 210000002700 urine Anatomy 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- WXKPPMQZRGORPB-UHFFFAOYSA-M sodium;2-hydroxypropane-1,2,3-tricarboxylic acid;acetate Chemical compound [Na+].CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O WXKPPMQZRGORPB-UHFFFAOYSA-M 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 6
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 6
- 229940098773 bovine serum albumin Drugs 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 206010003445 Ascites Diseases 0.000 claims description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 claims description 3
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
- 238000011587 new zealand white rabbit Methods 0.000 claims description 3
- 210000004988 splenocyte Anatomy 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 2
- 210000004989 spleen cell Anatomy 0.000 claims description 2
- 238000010257 thawing Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims 4
- 238000010521 absorption reaction Methods 0.000 claims 3
- 230000001900 immune effect Effects 0.000 claims 3
- 238000010790 dilution Methods 0.000 claims 2
- 239000012895 dilution Substances 0.000 claims 2
- 229940035429 isobutyl alcohol Drugs 0.000 claims 2
- 238000002203 pretreatment Methods 0.000 claims 2
- 238000010241 blood sampling Methods 0.000 claims 1
- HFNQLYDPNAZRCH-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O.OC(O)=O HFNQLYDPNAZRCH-UHFFFAOYSA-N 0.000 claims 1
- 239000007979 citrate buffer Substances 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000004445 quantitative analysis Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 238000005057 refrigeration Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 238000003805 vibration mixing Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 28
- 238000002649 immunization Methods 0.000 abstract description 15
- 239000011248 coating agent Substances 0.000 abstract description 3
- 238000000576 coating method Methods 0.000 abstract description 3
- 239000003547 immunosorbent Substances 0.000 abstract description 3
- 239000011543 agarose gel Substances 0.000 abstract description 2
- 238000011091 antibody purification Methods 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 23
- 239000000499 gel Substances 0.000 description 19
- 239000003085 diluting agent Substances 0.000 description 12
- 239000000048 adrenergic agonist Substances 0.000 description 10
- 108010058846 Ovalbumin Proteins 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- 208000005374 Poisoning Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 4
- 229960001117 clenbuterol Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229940092253 ovalbumin Drugs 0.000 description 4
- 231100000572 poisoning Toxicity 0.000 description 4
- 230000000607 poisoning effect Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 235000021336 beef liver Nutrition 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 150000003943 catecholamines Chemical class 0.000 description 3
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 229940072221 immunoglobulins Drugs 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 238000011097 chromatography purification Methods 0.000 description 2
- 238000009535 clinical urine test Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000007863 gel particle Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229960002052 salbutamol Drugs 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- BUXRLJCGHZZYNE-UHFFFAOYSA-N 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile Chemical compound CC(C)NCC(O)C1=CC=C(N)C(C#N)=C1 BUXRLJCGHZZYNE-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 231100000703 Maximum Residue Limit Toxicity 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950010971 cimaterol Drugs 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
本发明涉及一种莱克多巴胺RCT的检测方法,更确切地说它是利用免疫亲和层析柱及酶联免疫吸附方法来检测食品中的莱克多巴胺残留,属于免疫学和食品安全检测技术领域。本发明的方法是:首先通过合成免疫抗原,包被抗原,动物免疫,抗体纯化等步骤制备多克隆抗体,再将此抗体交联到琼脂糖凝胶上,制备免疫亲和层析柱。被检样品经处理后,通过亲和柱以富集其中的莱克多巴胺;收集亲和柱的洗脱液进行酶联免疫吸附检测,以确定其中的莱克多巴胺含量。The invention relates to a method for detecting ractopamine RCT. More precisely, it uses an immunoaffinity chromatography column and an enzyme-linked immunosorbent method to detect ractopamine residues in food, and belongs to the technical field of immunology and food safety detection. The method of the invention is as follows: firstly, the polyclonal antibody is prepared through the steps of synthesizing the immune antigen, coating the antigen, animal immunization, antibody purification, etc., and then cross-linking the antibody to the agarose gel to prepare the immunoaffinity chromatography column. After the tested sample is processed, it passes through the affinity column to enrich the ractopamine therein; the eluate from the affinity column is collected for enzyme-linked immunosorbent assay to determine the content of ractopamine therein.
Description
技术领域technical field
本发明属于免疫分析技术领域。具体而言,涉及一种莱克多巴胺(RCT)亲和层析-酶联免疫检测方法及其专用检测试剂盒。The invention belongs to the technical field of immune analysis. Specifically, it relates to a ractopamine (RCT) affinity chromatography-ELISA detection method and a special detection kit thereof.
背景技术Background technique
莱克多巴胺(Ractopamine)是β2-肾上腺素能激动剂(BAA)成员之一,与“瘦肉精”同属儿茶酚胺类(肾上腺素和去甲肾上腺素BAA)物质。早在本世纪50年代末期就发现,儿茶酚胺类(肾上腺素和去甲肾上腺素)能刺激脂肪组织释放脂肪酸,并增加蛋白质沉积,但直到70年代初期,儿茶酚胺类物质及其类似物改善机体营养调配和胴体组成的能力,才首先由美国氰胺公司研究部所认识。随后便大规模用于畜禽生产以提高瘦肉率,减少脂肪沉积,及增加产奶量等。Ractopamine is one of the members of β2-adrenergic agonist (BAA), and it belongs to catecholamines (adrenaline and norepinephrine BAA) substances like "leptbuterol". As early as the late 1950s, it was discovered that catecholamines (epinephrine and norepinephrine) could stimulate fatty tissue to release fatty acids and increase protein deposition, but it was not until the early 1970s that catecholamines and their analogs improved the body's nutritional allocation The ability to form and carcass was first recognized by the American Cyamide Research Department. Then it is used on a large scale in livestock and poultry production to increase lean meat percentage, reduce fat deposition, and increase milk production.
BAA用作营养重分配剂的实用性开发研究始于70年代末期。二十几年来,以美国几家大公司和研究室为首,已开发出数百种结构类似药,经过对大鼠、牛、绵羊、猪、禽等的数百次逾万头(只)动物试验,筛选出促生长作用较强的BAA十余种。其中实用型BAA有莱克多巴胺(ractopamine)、克仑特罗(clenbuterol)、沙丁胺醇(salbutamol)、赛曼特罗(cimaterol)、吡啶甲醇类、脱脂BAA。其中菜克多巴胺、克仑特罗、沙丁胺醇因其口服效率高在生产中常用。The practical development and research of BAA as a nutrient redistribution agent began in the late 1970s. Over the past two decades, led by several large companies and research laboratories in the United States, hundreds of structurally similar drugs have been developed. After hundreds of tests on rats, cattle, sheep, pigs, poultry, etc., more than ten thousand (only) animals More than ten kinds of BAA with strong growth-promoting effect were screened out. Among them, practical BAAs include ractopamine, clenbuterol, salbutamol, cimaterol, pyridinemethanol, and defatted BAA. Among them, ractopamine, clenbuterol, and albuterol are commonly used in production because of their high oral efficiency.
据Kuiper(1998)综述,1989年,西班牙中部发生135人因食用含β2-肾上腺素能激动剂残留物的牛肝而集体中毒的事件;1992年西班牙北部又有232人因同样原因而集体中毒;1995年西班牙的巴塞罗那地区发生15起β2-肾上腺素能激动剂中毒事件;1990-1991年,法国里昂地区有8个家庭因食用残留β2-肾上腺素能激动剂的牛肝而集体中毒;1996年,仅意大利就发生62起因食用残留有β2-肾上腺素能激动剂的牛肉和牛肝而集体中毒的事件;中毒症状有肌肉震颤、心悸、神经过敏、头痛、肌肉疼、目晕、恶心、呕吐、发烧、战栗。进食40小时后病人尿中仍可检出β2-肾上腺素能激动剂。有心脏病史的人对食物残留β2-肾上腺素能激动剂尤为敏感(尹靖东等,1998)。因此欧盟采取了严密的措施,通过一系列法规条例严格控制莱克多巴胺、克仑特罗进入市场。除特殊情况外任何动物体内有β2-肾上腺素能激动剂残留都是违法的。According to Kuiper (1998), in 1989, 135 people were collectively poisoned by eating beef liver containing β2-adrenergic agonist residues in central Spain; in 1992, another 232 people were collectively poisoned by the same reason in northern Spain ; In 1995, 15 cases of β2-adrenergic agonist poisoning occurred in Barcelona, Spain; from 1990 to 1991, 8 families in Lyon, France were collectively poisoned by eating beef liver with residual β2-adrenergic agonists; 1996 In 2010, there were 62 mass poisoning incidents in Italy alone due to consumption of beef and beef liver with residual β2-adrenergic agonists; symptoms of poisoning include muscle tremors, palpitations, nervousness, headache, muscle pain, dizziness, nausea, and vomiting , fever, tremors. Beta2-adrenergic agonists can still be detected in the patient's
目前许多国家对莱克多巴胺提出了最高残留限量,如英国在动物可食性组织的最大残留量为0.5ng/g,荷兰规定肝组织最大残留量为1ng/g(G.A.Mitchell,et al,1998)。而我国也规定为1ng/g(肝组织)或1ng/ml(尿液)。At present, many countries have proposed the maximum residue limit for ractopamine, such as the maximum residue in animal edible tissue in the UK is 0.5ng/g, and the Netherlands stipulates that the maximum residue in liver tissue is 1ng/g (G.A.Mitchell, et al, 1998). In my country, it is also stipulated as 1ng/g (liver tissue) or 1ng/ml (urine).
我国农业部1997年3月[农牧发(1997)]3号文严令禁止β2-肾上腺素能激动剂在动物生产中的应用。但由于资金、技术等方面的原因,滥用β2-肾上腺素能激动剂的行为一直未能得到有效的遏止,2001年,连续发生了广东河源、广东信宜、浙江等地十几起上百人集体中毒的事件。In March 1997, the Ministry of Agriculture of my country issued a document No. 3 [Nong Mu Fa (1997)] to strictly prohibit the application of β2-adrenergic agonists in animal production. However, due to financial, technical and other reasons, the abuse of β2-adrenergic agonists has not been effectively curbed. In 2001, more than a dozen collective crimes involving hundreds of people occurred successively in Guangdong Heyuan, Guangdong Xinyi, Zhejiang and other places. poisoning incidents.
因此,需建立一种灵敏、特异、操作简单、适于大批量样品筛选的检测方法,才能对莱克多巴胺、克仑特罗类物质的非法使用进行及时、有效的监测。Therefore, it is necessary to establish a detection method that is sensitive, specific, easy to operate, and suitable for large-scale sample screening in order to monitor the illegal use of ractopamine and clenbuterol in a timely and effective manner.
目前的检测方法主要有高效液相色谱-质谱联用法(HPLC-MS)和气相色谱-质谱联用法(GC-MS)。这些仪器分析技术一般耗时,价贵,大批量检测困难,操作繁琐,均不能适应市场监督需要快速、简便、价廉的要求。The current detection methods mainly include high performance liquid chromatography-mass spectrometry (HPLC-MS) and gas chromatography-mass spectrometry (GC-MS). These instrumental analysis techniques are generally time-consuming, expensive, difficult to detect in large quantities, and cumbersome to operate, all of which cannot meet the requirements of fast, simple, and cheap market supervision.
发明内容Contents of the invention
本发明目的在于提供一种样品前处理简单,灵敏度高,特异性强,快速高效,适于大批量样品筛选的莱克多巴胺检测方法,并开发结构简单,使用方便,价格便宜,便于携带的莱克多巴胺检测试剂盒。The purpose of the present invention is to provide a ractopamine detection method that is simple in sample pretreatment, high in sensitivity, strong in specificity, fast and efficient, and suitable for large-scale sample screening, and develops ractopamine with simple structure, convenient use, cheap price and portability Detection kit.
发明人主要采用亲和层析-酶联免疫吸附方法(IAC-ELISA)检测RCT;先利用免疫亲和层析方法将检测样品中的RCT加以富集纯化,再通过酶联免疫吸附方法对其进行定量检测;完成了本发明。The inventor mainly adopts affinity chromatography-enzyme-linked immunosorbent method (IAC-ELISA) to detect RCT; utilize immunoaffinity chromatography method to carry out enrichment and purification to the RCT in the detection sample, then pass ELISA method to its RCT. Carry out quantitative detection; Complete the present invention.
本发明提供了一种利用免疫亲和层析和酶联免疫吸附检测样品中莱克多巴胺RCT的方法,包括步骤:The invention provides a method for detecting ractopamine RCT in a sample by using immunoaffinity chromatography and enzyme-linked immunosorbent adsorption, comprising the steps of:
(1)样品前处理;(1) Sample pretreatment;
(2)制备酶标抗原:将活化的辣根过氧化物酶与纯化的RCT混合,制备酶标抗原;(2) Prepare enzyme-labeled antigen: mix activated horseradish peroxidase with purified RCT to prepare enzyme-labeled antigen;
(3)制备RCT抗体;(3) Preparation of RCT antibody;
(4)制备偶联RCT抗体的凝胶;(4) prepare the gel of coupling RCT antibody;
(5)包被酶标板;(5) coated microtiter plate;
(6)免疫亲和层析纯化:将偶联抗体的凝胶装柱,加入样品过柱,洗脱,收集洗脱液;(6) Immunoaffinity chromatography purification: the gel coupled with the antibody is packed into a column, the sample is added to pass through the column, eluted, and the eluate is collected;
(7)酶联免疫吸附检测:将洗脱液加入经抗体包被的酶标板上,温育后洗涤拍干;加入酶标抗原,温育后洗涤拍干;显色、终止;用酶标仪读取OD值;(7) Enzyme-linked immunosorbent assay: Add the eluate to the antibody-coated ELISA plate, wash and pat dry after incubation; add enzyme-labeled antigen, wash and pat dry after incubation; develop color, terminate; The standard instrument reads the OD value;
(8)绘制标准曲线;(8) Draw a standard curve;
(9)根据标准曲线对洗脱液中的RCT含量进行定量计算。(9) Quantitatively calculate the RCT content in the eluate according to the standard curve.
优选地,样品前处理采用称取动物制品,加入HCl匀浆,冻融,离心取上清,加入NaOH调解pH值至11,加入异丁醇,振荡,静置,定量吸取异丁醇,水浴蒸干,再加入磷酸盐溶液溶解析出物,冻存待测;或取动物尿液,离心去除杂质,取上清待测。Preferably, the sample pretreatment is by weighing animal products, adding HCl to homogenate, freezing and thawing, centrifuging to take the supernatant, adding NaOH to adjust the pH value to 11, adding isobutanol, shaking, standing still, quantitatively absorbing isobutanol, water bath Evaporate to dryness, then add phosphate solution to dissolve the precipitate, and freeze it for testing; or take animal urine, centrifuge to remove impurities, and take the supernatant for testing.
优选地,制备酶标抗原采用将活化的辣根过氧化物酶与纯化的RCT混合,在碳酸缓冲体系中进行标记反应,之后加入硼氢化钠还原未结合位点;其中制备RCT抗体采用将RCT与牛血清白蛋白BSA或与卵清白蛋白OVA偶联作为抗原,制备多克隆RCT抗体或单克隆RCT抗体。Preferably, the enzyme-labeled antigen is prepared by mixing activated horseradish peroxidase with purified RCT, performing a labeling reaction in a carbonic acid buffer system, and then adding sodium borohydride to reduce the unbound site; wherein RCT antibody is prepared using RCT Conjugate bovine serum albumin BSA or ovalbumin OVA as an antigen to prepare polyclonal RCT antibody or monoclonal RCT antibody.
优选地,制备多克隆RCT抗体的方法采用将新西兰白兔接种免疫,免疫抗原为BSA-RCT或OVA-RCT,放血;分级沉淀血清中杂蛋白和抗体免疫球蛋白,离心后得含有多克隆RCT抗体的溶液,冻存备用。Preferably, the method for preparing the polyclonal RCT antibody is to inoculate and immunize New Zealand white rabbits, the immunization antigen is BSA-RCT or OVA-RCT, and bloodletting; the miscellaneous proteins and antibody immunoglobulins in the serum are fractionated and precipitated, and polyclonal RCT is obtained after centrifugation. The antibody solution was frozen for later use.
优选地,制备单克隆RCT抗体的方法采用将小鼠接种免疫,免疫抗原为BSA-RCT或OVA-RCT,采血,测定抗体效价,取脾细胞;将脾细胞与骨髓瘤细胞进行融合;筛选杂交瘤细胞,获得完全同质的单克隆抗体和稳定的单克隆杂交瘤细胞株;在小鼠腹腔内注射杂交瘤细胞,采集腹水,经提纯后待用。Preferably, the method for preparing the monoclonal RCT antibody is to inoculate and immunize mice, the immune antigen is BSA-RCT or OVA-RCT, blood is collected, the antibody titer is determined, and splenocytes are taken; splenocytes are fused with myeloma cells; screening Hybridoma cells, to obtain completely homogeneous monoclonal antibodies and stable monoclonal hybridoma cell lines; intraperitoneally inject hybridoma cells in mice, collect ascites, and use after purification.
优选地,制备偶联RCT抗体的凝胶采用先活化凝胶;将活化后的凝胶与RCT抗体振荡混匀;离心洗涤以洗脱杂蛋白和未结合的抗体;依次用不同pH梯度溶液轮流洗涤封闭未结合的活性基团,再用磷酸缓冲液淋洗,冷藏保存备用。Preferably, the gel coupled with the RCT antibody is prepared by first activating the gel; shaking and mixing the activated gel with the RCT antibody; centrifuging and washing to elute foreign proteins and unbound antibodies; alternately using different pH gradient solutions Wash and block unbound active groups, rinse with phosphate buffer, and store in cold storage for later use.
优选地,包被酶标板采用将RCT抗体包被在酶标板上,冷藏过夜;洗涤拍干。Preferably, the coated microtiter plate is coated with the RCT antibody on the microtiter plate, refrigerated overnight; washed and patted dry.
优选地,免疫亲和层析纯化采用将偶联抗体的凝胶装柱,加入样品,循环过柱,用甘氨酸溶液洗脱,收集洗脱液。Preferably, the immunoaffinity chromatography purification is performed by packing the gel coupled with the antibody into a column, adding a sample, circulating through the column, eluting with a glycine solution, and collecting the eluate.
优选地,酶联免疫吸附检测采用将样品洗脱液加在包被后的酶标板上,温育后洗涤拍干;加入酶标抗原,温育后洗涤拍干;继而加入底物混合液显色;终止反应;用酶标仪读取OD值。Preferably, the enzyme-linked immunosorbent assay adopts the method of adding the sample eluent to the coated ELISA plate, washing and patting dry after incubation; adding enzyme-labeled antigen, washing and patting dry after incubation; then adding the substrate mixture Color development; stop the reaction; read the OD value with a microplate reader.
本发明还提供了一种用于所述方法的试剂盒,其特征在于它包括:The present invention also provides a kit for the method, characterized in that it comprises:
A试剂:标准RCT试剂;A reagent: standard RCT reagent;
C试剂:酶标抗原试剂;C reagent: enzyme-labeled antigen reagent;
K试剂:偶联RCT抗体的凝胶;K reagent: gel coupled with RCT antibody;
包被RCT抗体的酶标板。A microtiter plate coated with RCT antibody.
优选地,所述的试剂盒还包括:Preferably, the kit also includes:
B试剂:稀释液;B reagent: diluent;
D试剂:酶标抗原稀释液D reagent: enzyme-labeled antigen diluent
E试剂:含吐温-20的磷酸盐PBS固体;E reagent: phosphate PBS solid containing Tween-20;
F试剂:邻苯二胺试剂;F reagent: o-phenylenediamine reagent;
G试剂:醋酸钠-柠檬酸缓冲液;G reagent: sodium acetate-citric acid buffer;
H试剂:30%H2O2;H reagent: 30% H 2 O 2 ;
I试剂:硫酸溶液;I reagent: sulfuric acid solution;
J试剂:甘氨酸溶液。J reagent: glycine solution.
本发明技术方案详述如下:Technical solution of the present invention is described in detail as follows:
1、样品前处理:1. Sample pretreatment:
动物制品(包括肝、肺、心、肾、肌肉)称取10g,加入50ml 0.1mol/LHCl进行组织匀浆,冻融两次,离心取上清,用10mol/L NaOH调节pH值到11,再加入异丁醇30ml,振荡30min,静置4h,定量吸取异丁醇,水浴蒸干,再加入1ml磷酸盐溶液(PBS,0.01mol/L,pH7.4)溶解析出物,冻存待测;Weigh 10g of animal products (including liver, lung, heart, kidney, muscle), add 50ml 0.1mol/L HCl for tissue homogenization, freeze and thaw twice, centrifuge to get the supernatant, adjust the pH value to 11 with 10mol/L NaOH, Then add 30ml of isobutanol, shake for 30min, let it stand for 4h, quantitatively absorb isobutanol, evaporate to dryness in a water bath, then add 1ml of phosphate solution (PBS, 0.01mol/L, pH7.4) to dissolve the eluate, and freeze it for testing ;
动物尿样,离心去除杂质后,取上清待测。Animal urine samples were centrifuged to remove impurities, and the supernatant was taken for testing.
2、制备酶标抗原:将活化的辣根过氧化物酶与纯化的RCT混合,在碳酸缓冲体系中进行标记反应,之后加入硼氢化钠还原未结合位点;2. Preparation of enzyme-labeled antigen: mix activated horseradish peroxidase with purified RCT, perform labeling reaction in carbonic acid buffer system, and then add sodium borohydride to reduce unbound sites;
3、制备RCT抗体3. Preparation of RCT antibody
将RCT与牛血清白蛋白BSA或与卵清白蛋白OVA偶联作为抗原,制备多克隆RCT抗体或单克隆RCT抗体;Coupling RCT with bovine serum albumin BSA or ovalbumin OVA as an antigen to prepare polyclonal RCT antibody or monoclonal RCT antibody;
其中制备多克隆RCT抗体的方法:Wherein the method for preparing the polyclonal RCT antibody:
将RCT与牛血清白蛋白(BSA)偶联或与卵清白蛋白(OVA)偶联制备抗原;免疫剂量每次1mg/ml BSA-RCT或OVA-RCT,首次免疫用1ml完全福氏佐剂乳化,加强免疫时用1ml不完全福氏佐剂乳化;将新西兰白兔饲养数周后接种免疫,每次免疫间隔两周,一共免疫5次。在最后一次直接肌肉注射,一周后采血检测抗体效价。之后颈动脉放血;以30%-60%的硫酸铵分级沉淀血清中杂蛋白和抗体免疫球蛋白,离心后得含有多克隆RCT抗体的溶液;-70℃保存备用。Coupling RCT with bovine serum albumin (BSA) or ovalbumin (OVA) to prepare antigen; immunization dose 1mg/ml BSA-RCT or OVA-RCT each time, emulsified with 1ml complete Freund's adjuvant for the first immunization , emulsified with 1ml incomplete Freund's adjuvant for booster immunization; New Zealand white rabbits were raised for several weeks and then immunized, with an interval of two weeks between each immunization, and a total of 5 immunizations. After the last direct intramuscular injection, blood was collected to detect the antibody titer one week later. Afterwards, the carotid artery was bled; miscellaneous proteins and antibody immunoglobulins in the serum were fractionally precipitated with 30%-60% ammonium sulfate, and centrifuged to obtain a solution containing polyclonal RCT antibodies; stored at -70°C for later use.
其中制备单克隆RCT抗体的方法:Wherein the method for preparing the monoclonal RCT antibody:
将RCT与牛血清白蛋白(BSA)偶联或与卵清白蛋白(OVA)偶联制备抗原;采用小鼠作为免疫动物,免疫抗原剂量为50ug(0.1ml)加等体积的完全福式佐剂乳化,进行首次免疫;一月后,取同等量免疫抗原加不完全福式佐剂,乳化,进行加强免疫,二免后,十天采血,测定抗体效价,取脾细胞;将脾细胞按5∶1比例与SP2/0骨髓瘤细胞进行融合;采用有限稀释法筛选杂交瘤细胞,得到完全同质的单克隆抗体和稳定的单克隆杂交瘤细胞株;在小鼠腹腔内注射一定量的杂交瘤细胞,采集腹水,经提纯后待用。Coupling RCT with bovine serum albumin (BSA) or ovalbumin (OVA) to prepare antigen; using mice as immunized animals, the dose of immunizing antigen is 50ug (0.1ml) plus an equal volume of complete Freudian adjuvant Emulsify for the first immunization; one month later, take the same amount of immune antigen plus incomplete Ford’s adjuvant, emulsify, and carry out booster immunization. After the second immunization, blood is collected ten days to determine the antibody titer, and spleen cells are collected; Fusion with SP2/0 myeloma cells at a ratio of 5:1; hybridoma cells were screened by limiting dilution method to obtain completely homogeneous monoclonal antibodies and stable monoclonal hybridoma cell lines; a certain amount of Ascites was collected for hybridoma cells and purified for use.
4、制备偶联抗体的sepharose-4B凝胶4. Preparation of sepharose-4B gel coupled with antibody
用溴化氰CNBr活化sepharose-4B琼脂糖凝胶;并用低浓度HCl溶液反复洗涤凝胶;在偶联抗体前先用磷酸缓冲液平衡sepharose-4B凝胶;将凝胶与适当稀释的RCT抗体振荡混匀,使抗体吸附到活化的sepharose-4B凝胶颗粒上;离心洗涤以洗脱杂蛋白和未结合的抗体;依次用不同pH溶液轮流洗涤封闭未结合的活性基团,再用磷酸缓冲液(加入0.02%NaN3)淋洗,4℃保存备用。Activate sepharose-4B agarose gel with cyanogen bromide CNBr; wash the gel repeatedly with low concentration HCl solution; Shake and mix well to make the antibody adsorb to the activated sepharose-4B gel particles; centrifuge and wash to elute the impurity protein and unbound antibody; wash with different pH solutions in turn to block the unbound active group, and then use phosphate buffer solution (with the addition of 0.02% NaN 3 ), and stored at 4°C for future use.
5、配制试剂5. Preparation of reagents
标准RCT试剂:RCT标准品加稀释液(PBS磷酸缓冲溶液pH7.4)混匀,配成梯度溶液。Standard RCT reagent: RCT standard plus diluent (PBS phosphate buffer solution pH 7.4) and mix well to make a gradient solution.
酶标抗原试剂:酶标抗原加10ml酶标抗原稀释液(PBS磷酸缓冲溶液,含1%的明胶,pH7.4)溶解,混匀。Enzyme-labeled antigen reagent: add 10ml enzyme-labeled antigen diluent (PBS phosphate buffer solution, containing 1% gelatin, pH7.4) to dissolve the enzyme-labeled antigen, and mix well.
洗涤液配制:在含有0.1%吐温-20的磷酸盐(PBS)固体中加入200ml蒸馏水配制洗涤液,用于酶标板的洗涤。Washing solution preparation: Add 200ml of distilled water to the phosphate (PBS) solid containing 0.1% Tween-20 to prepare a washing solution for washing the microtiter plate.
底物混合液的配制:用20ml醋酸钠-柠檬酸缓冲液稀释40mg邻苯二胺,再加入6ul 30%H2O2,配制成底物混合液,现用现配。Preparation of the substrate mixture: dilute 40 mg of o-phenylenediamine with 20 ml of sodium acetate-citric acid buffer solution, and then add 6 ul of 30% H 2 O 2 to prepare the substrate mixture, which is ready-to-use.
6、包被酶标板:将RCT抗体(单克隆抗体或多克隆抗体)包被在酶标板上,冷藏过夜;洗涤拍干;将抗体包被在酶标板上,100ul/孔,放入4℃冰箱过夜。再加入洗涤液,250ul/孔,洗涤3次,每次3min;放在吸水纸上拍干。6. Coating microtiter plate: coat RCT antibody (monoclonal antibody or polyclonal antibody) on microtiter plate, refrigerate overnight; wash and pat dry; coat antibody on microtiter plate, 100ul/well, put Into 4 ℃ refrigerator overnight. Then add washing solution, 250ul/well, wash 3 times, 3min each time; put on absorbent paper and pat dry.
7、取5ml偶联抗体sepharose-4B凝胶装柱,先加入洗涤液平衡,直至流出液的OD280值小于0.5。再加入等体积待测样品溶液,4℃循环过柱。之后用0.1mol/L pH2.5甘氨酸溶液洗脱,收集洗脱液。7. Take 5ml of conjugated antibody sepharose-4B gel and pack it into the column, add washing solution to balance until the OD280 value of the effluent is less than 0.5. Then add an equal volume of the sample solution to be tested, and circulate through the column at 4°C. Then eluted with 0.1mol/L pH2.5 glycine solution, and collected the eluate.
8、在酶标板中加入待测样品洗脱液和RCT标准溶液;37℃温育0.5h;之后洗涤拍干;加入100ul酶标抗原溶液,37℃温育0.5h;洗涤拍干;每孔加入150ul底物混合液,室温显色15min;每孔加入50ul终止液(硫酸溶液);酶标仪读取各孔OD值。8. Add the eluent of the sample to be tested and the RCT standard solution to the microplate; incubate at 37°C for 0.5h; then wash and pat dry; add 100ul enzyme-labeled antigen solution, incubate at 37°C for 0.5h; wash and pat dry; Add 150ul of substrate mixture to each well, and develop color at room temperature for 15min; add 50ul of stop solution (sulfuric acid solution) to each well; read the OD value of each well with a microplate reader.
9、绘制标准曲线:用RCT标准品所获各梯度溶液OD值,绘制标准曲线;9. Draw a standard curve: use the OD value of each gradient solution obtained from the RCT standard to draw a standard curve;
10、根据标准曲线对样品洗脱液中的RCT含量进行定量计算。10. Quantitatively calculate the RCT content in the sample eluate according to the standard curve.
结果判定:标准对照孔的OD值随着RCT浓度的下降而升高,将样品检测孔OD值与标准对照孔的OD值比较,若OD值相同则被检样品中的RCT含量与对应标准溶液的RCT浓度相同。Result judgment: The OD value of the standard control well increases with the decrease of the RCT concentration. Compare the OD value of the sample detection well with the OD value of the standard control well. If the OD value is the same, the RCT content in the tested sample is the same as the corresponding standard solution. RCTs with the same concentration.
本发明RCT检测试剂盒的组建:The formation of RCT detection kit of the present invention:
试剂盒包含:包被RCT抗体的酶标板;A试剂:标准RCT试剂;B试剂:稀释液;C试剂:酶标抗原试剂;D试剂:酶标抗原稀释液;E试剂:含吐温-20的磷酸盐PBS固体;F试剂:邻苯二胺试剂;G试剂:醋酸钠-柠檬酸缓冲液;H试剂:30%H2O2);I试剂:硫酸溶液;J试剂:甘氨酸溶液;K试剂:偶联抗体sepharose-4B凝胶。The kit includes: ELISA plate coated with RCT antibody; A reagent: standard RCT reagent; B reagent: diluent; C reagent: enzyme-labeled antigen reagent; D reagent: enzyme-labeled antigen diluent; E reagent: containing Tween- 20 phosphate PBS solid; F reagent: o-phenylenediamine reagent; G reagent: sodium acetate-citric acid buffer; H reagent: 30% H 2 O 2 ); I reagent: sulfuric acid solution; J reagent: glycine solution; K reagent: conjugated antibody sepharose-4B gel.
其中RCT抗体可以是多克隆RCT抗体或单克隆RCT抗体。Wherein the RCT antibody can be a polyclonal RCT antibody or a monoclonal RCT antibody.
酶联免疫吸附检测法(ELISA)是一种快速检测方法,不需要复杂的仪器设备,灵敏度高,特异性强,样品前处理简单,非常适合大量样品的检测,便于现场监控。目前已经广泛应用于各个研究领域。免疫亲和层析纯化技术(IAC)是一种富集纯化物质的高效技术,IAC与ELISA的结合大大的提高了检测的灵敏度。Enzyme-linked immunosorbent assay (ELISA) is a rapid detection method that does not require complex equipment, has high sensitivity, strong specificity, and simple sample pretreatment. It is very suitable for the detection of a large number of samples and is convenient for on-site monitoring. It has been widely used in various research fields. Immunoaffinity chromatography (IAC) is an efficient technology for enriching and purifying substances. The combination of IAC and ELISA greatly improves the sensitivity of detection.
用ELISA方法实现了对莱克多巴胺的检测,该项研究填补了国内该领域的研究空白。最后创造性将IAC技术与ELISA技术结合起来实现了莱克多巴胺的特异性检测。The detection of ractopamine was realized by ELISA method, and this research filled the research gap in this field in China. Finally, the specific detection of ractopamine was realized by creatively combining IAC technology with ELISA technology.
使用IAC-ELISA检测技术对样品中的莱克多巴胺可以达到1ng/mL的检测限。Using IAC-ELISA detection technology, the detection limit of ractopamine in the sample can reach 1ng/mL.
本发明所述方法优点如下:Method advantage of the present invention is as follows:
1、灵敏度高,检测限低,回收率高,结果重复性好;1. High sensitivity, low detection limit, high recovery rate and good repeatability of results;
2、特异性强:IAC和ELISA方法均建立在抗体和抗原的特异性结合,且所得抗体交叉反应率极低;2. Strong specificity: Both IAC and ELISA methods are based on the specific combination of antibodies and antigens, and the obtained antibody cross-reactivity rate is extremely low;
3、检测成本低廉,无需大型仪器设备,适于推广;3. The detection cost is low, no large-scale equipment is required, and it is suitable for promotion;
4、样品预处理简单,无需无菌化处理,样品提取方便快捷;4. The sample pretreatment is simple, without aseptic treatment, and the sample extraction is convenient and fast;
5、通过酶标仪判读,结果具有客观性和不可更改性;5. Interpreted by a microplate reader, the results are objective and unchangeable;
6、简单易行,操作人员只需最基本的实验知识,可标准化为产品;6. Simple and easy to operate, operators only need the most basic experimental knowledge, and can be standardized into products;
7、检测时间短,整个操作过程不到2.5个小时;7. The detection time is short, the whole operation process is less than 2.5 hours;
8、可以进行大批量检测。8. Can carry out mass inspection.
附图说明Description of drawings
图1:多克隆抗体检测RCT的标准曲线图。Figure 1: Standard curves for polyclonal antibody detection RCTs.
图2:单克隆抗体检测RCT的标准曲线图。Figure 2: Standard curves for monoclonal antibody detection RCTs.
具体实施方式Detailed ways
下面结合具体实例,进一步阐述本发明。应理解,这些实例仅用于说明本发明而不用于限制本发明的范围。Below in conjunction with specific example, further set forth the present invention. It should be understood that these examples are only for illustrating the present invention and are not intended to limit the scope of the present invention.
实施例1:Example 1:
1、样品前处理:1. Sample pretreatment:
猪肉制品(包括肝、肺、心、肾、肌肉)称取10g,加入50ml 0.1mol/LHCl进行组织匀浆,冻融两次,离心取上清,用10mol/L NaOH调节pH值到11,再加入异丁醇30ml,振荡30min,静置4h,定量吸取异丁醇,水浴蒸干,再加入1ml磷酸盐溶液(PBS,0.01mol/L,pH7.4)溶解析出物,冻存待测;Weigh 10g of pork products (including liver, lung, heart, kidney, muscle), add 50ml 0.1mol/L HCl for tissue homogenization, freeze and thaw twice, centrifuge to get the supernatant, adjust the pH value to 11 with 10mol/L NaOH, Then add 30ml of isobutanol, shake for 30min, let it stand for 4h, quantitatively absorb isobutanol, evaporate to dryness in a water bath, then add 1ml of phosphate solution (PBS, 0.01mol/L, pH7.4) to dissolve the eluate, and freeze it for testing ;
猪尿样,离心去除杂质后,取上清待测。Pig urine samples were centrifuged to remove impurities, and the supernatant was taken for testing.
2、制备酶标抗原:将活化的辣根过氧化物酶与纯化的RCT混合,在碳酸缓冲体系中进行标记反应,之后加入硼氢化钠还原未结合位点;2. Preparation of enzyme-labeled antigen: mix activated horseradish peroxidase with purified RCT, perform labeling reaction in carbonic acid buffer system, and then add sodium borohydride to reduce unbound sites;
3、制备RCT抗体3. Preparation of RCT antibody
将RCT与牛血清白蛋白BSA偶联制备抗原;免疫剂量每次1mg/ml BSA-RCT,首次免疫用1ml完全福氏佐剂乳化,加强免疫时用1ml不完全福氏佐剂乳化;将新西兰白兔饲养数周后接种免疫,每次免疫间隔两周,一共免疫5次。在最后一次直接肌肉注射,一周后采血检测抗体效价。之后颈动脉放血;以30%-60%的硫酸铵分级沉淀血清中杂蛋白和抗体免疫球蛋白,离心后得含有多克隆RCT抗体的溶液;-70℃保存备用。Coupling RCT with bovine serum albumin BSA to prepare antigen; immunization dose 1mg/ml BSA-RCT each time, emulsified with 1ml complete Freund's adjuvant for the first immunization, emulsified with 1ml incomplete Freund's adjuvant for booster immunization; New Zealand The white rabbits were immunized after being fed for several weeks, with a two-week interval between each immunization, and a total of 5 immunizations. After the last direct intramuscular injection, blood was collected to detect the antibody titer one week later. Afterwards, the carotid artery was bled; miscellaneous proteins and antibody immunoglobulins in the serum were fractionally precipitated with 30%-60% ammonium sulfate, and centrifuged to obtain a solution containing polyclonal RCT antibodies; stored at -70°C for later use.
4、制备偶联抗体的sepharose-4B凝胶4. Preparation of sepharose-4B gel coupled with antibody
用CNBr活化sepharose-4B凝胶;并用低浓度HCl溶液反复洗涤凝胶;在偶联抗体前先用磷酸缓冲液平衡sepharose-4B凝胶;将凝胶与适当稀释的多克隆RCT抗体振荡混匀,使抗体吸附到活化的sepharose-4B凝胶颗粒上;离心洗涤以洗脱杂蛋白和未结合的抗体;依次用不同pH溶液轮流洗涤封闭未结合的活性基团,再用磷酸缓冲液(加入0.02%NaN3)淋洗,4℃保存备用。Activate the sepharose-4B gel with CNBr; wash the gel repeatedly with low-concentration HCl solution; equilibrate the sepharose-4B gel with phosphate buffer before coupling the antibody; shake and mix the gel with an appropriately diluted polyclonal RCT antibody , so that the antibody is adsorbed to the activated sepharose-4B gel particles; centrifugal washing to elute the foreign protein and unbound antibody; sequentially wash with different pH solutions to block the unbound active group, and then use phosphate buffer (addition 0.02% NaN 3 ), and stored at 4°C for later use.
5、配制试剂5. Preparation of reagents
标准RCT试剂:RCT标准品加稀释液(PBS磷酸缓冲溶液,pH7.4)混匀,配成梯度溶液。Standard RCT reagent: RCT standard plus diluent (PBS phosphate buffer solution, pH 7.4) and mix well to prepare a gradient solution.
酶标抗原试剂:酶标抗原加10ml酶标抗原稀释液(PBS磷酸缓冲溶液,含1%的明胶,pH7.4)溶解,混匀。Enzyme-labeled antigen reagent: add 10ml enzyme-labeled antigen diluent (PBS phosphate buffer solution, containing 1% gelatin, pH7.4) to dissolve the enzyme-labeled antigen, and mix well.
洗涤液配制:在含有0.1%吐温-20的磷酸盐(PBS)固体中加入200ml蒸馏水配制洗涤液,用于酶标板的洗涤。Washing solution preparation: Add 200ml of distilled water to the phosphate (PBS) solid containing 0.1% Tween-20 to prepare a washing solution for washing the microtiter plate.
底物混合液的配制:用20ml醋酸钠-柠檬酸缓冲液稀释40mg邻苯二胺,再加入6ul 30%H2O2,配制成底物混合液,现用现配。Preparation of the substrate mixture: dilute 40 mg of o-phenylenediamine with 20 ml of sodium acetate-citric acid buffer solution, and then add 6 ul of 30% H 2 O 2 to prepare the substrate mixture, which is ready-to-use.
6、包被酶标板:将RCT多克隆抗体包被在酶标板上,冷藏过夜;洗涤拍干;将抗体包被在酶标板上,100ul/孔,放入4℃冰箱过夜。再加入洗涤液,250ul/孔,洗涤3次,每次3min;放在吸水纸上拍干。6. Enzyme plate coating: Coat the RCT polyclonal antibody on the plate and refrigerate overnight; wash and pat dry; coat the antibody on the plate, 100ul/well, and put it in a 4°C refrigerator overnight. Then add washing solution, 250ul/well, wash 3 times, 3min each time; put on absorbent paper and pat dry.
7、取5ml偶联抗体sepharose-4B凝胶装柱,先加入洗涤液平衡,直至流出液的OD280值小于0.5。再加入等体积待测样品溶液,4℃循环过柱。之后用0.1mol/L pH2.5甘氨酸溶液洗脱,收集洗脱液。7. Take 5ml of conjugated antibody sepharose-4B gel and pack it into the column, add washing solution to balance until the OD280 value of the effluent is less than 0.5. Then add an equal volume of the sample solution to be tested, and circulate through the column at 4°C. Then eluted with 0.1mol/L pH2.5 glycine solution, and collected the eluate.
8、在酶标板中加入待测样品洗脱液和RCT标准溶液;37℃温育0.5h;之后洗涤拍干;加入100ul酶标抗原溶液,37℃温育0.5h;洗涤拍干;每孔加入150ul底物混合液,室温显色15min;每孔加入50ul终止液(硫酸溶液);酶标仪读取各孔OD值。8. Add the eluent of the sample to be tested and the RCT standard solution to the microplate; incubate at 37°C for 0.5h; then wash and pat dry; add 100ul enzyme-labeled antigen solution, incubate at 37°C for 0.5h; wash and pat dry; Add 150ul of substrate mixture to each well, and develop color at room temperature for 15min; add 50ul of stop solution (sulfuric acid solution) to each well; read the OD value of each well with a microplate reader.
9、绘制标准曲线:用RCT标准品所获各梯度溶液OD值,绘制标准曲线;结果见图1。9. Draw a standard curve: use the OD value of each gradient solution obtained from the RCT standard to draw a standard curve; the results are shown in Figure 1.
10、根据标准曲线对样品洗脱液中的RCT含量进行定量计算。10. Quantitatively calculate the RCT content in the sample eluate according to the standard curve.
结果判定:标准对照孔的OD值随着RCT浓度的下降而升高,将样品检测孔OD值与标准对照孔的OD值比较,若OD值相同则被检样品中的RCT含量与对应标准溶液的RCT浓度相同,检测结果如下:Result judgment: The OD value of the standard control well increases with the decrease of the RCT concentration. Compare the OD value of the sample detection well with the OD value of the standard control well. If the OD value is the same, the RCT content in the tested sample is the same as the corresponding standard solution. The same concentration of RCT, the test results are as follows:
实施例2:Example 2:
RCT检测试剂盒的组建:The composition of the RCT detection kit:
试剂盒包含:包被单克隆RCT抗体的酶标板;A试剂:标准RCT试剂;B试剂:稀释液;C试剂:酶标抗原试剂;D试剂:酶标抗原稀释液;E试剂:含吐温-20的磷酸盐PBS固体;F试剂:邻苯二胺试剂;G试剂:醋酸钠-柠檬酸缓冲液;H试剂:30%H2O2);I试剂:硫酸溶液;J试剂:甘氨酸溶液;K试剂:偶联单克隆RCT抗体的sepharose-4B凝胶。The kit includes: ELISA plate coated with monoclonal RCT antibody; A reagent: standard RCT reagent; B reagent: diluent; C reagent: enzyme-labeled antigen reagent; D reagent: enzyme-labeled antigen diluent; E reagent: containing Tween -20 phosphate PBS solid; F reagent: o-phenylenediamine reagent; G reagent: sodium acetate-citric acid buffer; H reagent: 30% H 2 O 2 ); I reagent: sulfuric acid solution; J reagent: glycine solution ; Reagent K: sepharose-4B gel coupled with monoclonal RCT antibody.
实施例3:Example 3:
RCT检测试剂盒的组建:The composition of the RCT detection kit:
试剂盒包含:包被多克隆RCT抗体的酶标板;A试剂:标准RCT试剂;B试剂:稀释液;C试剂:酶标抗原试剂;D试剂:酶标抗原稀释液;E试剂:含吐温-20的磷酸盐PBS固体;F试剂:邻苯二胺试剂;G试剂:醋酸钠-柠檬酸缓冲液;H试剂:30%H2O2);I试剂:硫酸溶液;J试剂:甘氨酸溶液;K试剂:偶联多克隆RCT抗体的sepharose-4B凝胶。The kit includes: ELISA plate coated with polyclonal RCT antibody; A reagent: standard RCT reagent; B reagent: diluent; C reagent: enzyme-labeled antigen reagent; D reagent: enzyme-labeled antigen diluent; Phosphate PBS solid at temperature -20; F reagent: o-phenylenediamine reagent; G reagent: sodium acetate-citric acid buffer; H reagent: 30% H 2 O 2 ); I reagent: sulfuric acid solution; J reagent: glycine Solution; Reagent K: sepharose-4B gel conjugated polyclonal RCT antibody.
实施例4:应用实施例2试剂盒检测Embodiment 4: application embodiment 2 kit detects
以猪肉制品和猪尿样RCT的检测为例,说明试剂盒的具体检测步骤。Taking the detection of pork products and pig urine sample RCT as an example, the specific detection steps of the kit are illustrated.
1、样品前处理:1. Sample pretreatment:
称取猪肉制品(包括肝,肺,心,肾,肌肉)10g,加入50ml,0.1mol/L HCl进行组织匀浆,冻融两次,离心取上清,用10mol/L NaOH调节pH值到11,再加入异丁醇30ml,振荡30min,静置4h,定量吸取异丁醇,水浴蒸干,再加入1ml磷酸盐溶液(PBS,0.01mol/L,pH7.4)溶解析出物,冻存待测。Weigh 10g of pork products (including liver, lung, heart, kidney, muscle), add 50ml, 0.1mol/L HCl for tissue homogenization, freeze and thaw twice, centrifuge to get the supernatant, adjust the pH value to 11. Add 30ml of isobutanol, shake for 30min, let it stand for 4h, absorb isobutanol quantitatively, evaporate to dryness in a water bath, add 1ml of phosphate solution (PBS, 0.01mol/L, pH7.4) to dissolve the eluate, and freeze to be tested.
猪尿样,离心去除杂质后,取上清待测。Pig urine samples were centrifuged to remove impurities, and the supernatant was taken for testing.
2、试剂的配制2. Preparation of reagents
标准RCT试剂:A试剂加B试剂混匀,配成梯度溶液。Standard RCT reagents: mix reagent A and reagent B to form a gradient solution.
酶标抗原试剂:C试剂加10ml D试剂溶解,混匀。Enzyme-labeled antigen reagent: C reagent plus 10ml D reagent to dissolve, mix well.
E洗涤液配制:在E试剂中加入200ml蒸馏水配制E洗涤液,用于酶标板的洗涤。Preparation of washing solution E: add 200ml of distilled water to reagent E to prepare washing solution E, which is used for washing the microtiter plate.
底物混合液的配制:用20ml G试剂稀释40mg F试剂,再加入6ul H试剂,配制成底物混合液,现用现配。Preparation of the substrate mixture: dilute 40mg of F reagent with 20ml of G reagent, then add 6ul of H reagent to prepare the substrate mixture, which is prepared immediately.
3、取5ml K试剂装柱,先加入E洗涤液平衡,直至流出液的OD280值小于0.5。再加入等体积待测样品溶液,4℃循环过柱。之后用J试剂洗脱,收集洗脱液。3. Take 5ml K reagent and pack it into the column, and add E washing solution to balance until the OD 280 value of the effluent is less than 0.5. Then add an equal volume of the sample solution to be tested, and circulate through the column at 4°C. Afterwards, it was eluted with reagent J, and the eluate was collected.
4、在包被单克隆RCT抗体的酶标板中加入待测样品洗脱液和RCT标准溶液;37℃温育0.5h;之后洗涤拍干。4. Add the eluent of the sample to be tested and the RCT standard solution to the ELISA plate coated with the monoclonal RCT antibody; incubate at 37°C for 0.5h; then wash and pat dry.
酶标板,第1排标准对照,在前11孔加入RCT梯度溶液,加入量100ul,第12孔加入空白对照。其余各孔则加入待测的样品洗脱液,加入量100ul。ELISA plate, the first row of standard control, add RCT gradient solution in the first 11 wells, the addition amount is 100ul, and add the blank control in the 12th well. The sample eluent to be tested was added to the remaining wells, and the amount added was 100ul.
5、加入100ul酶标抗原溶液,37℃温育0.5h;洗涤拍干;每孔加入150ul底物混合液,室温显色15min;每孔加入50ul I试剂终止;酶标仪读取各孔OD值。5. Add 100ul enzyme-labeled antigen solution, incubate at 37°C for 0.5h; wash and pat dry; add 150ul substrate mixture to each well, develop color at room temperature for 15min; add 50ul I reagent to each well to terminate; read OD of each well with a microplate reader value.
6、绘制标准曲线:用RCT标准品所获各梯度溶液OD值,绘制标准曲线;此方法的检测限为0.2ng/mL。结果如图2。6. Draw a standard curve: Use the OD value of each gradient solution obtained from the RCT standard to draw a standard curve; the detection limit of this method is 0.2 ng/mL. The result is shown in Figure 2.
7、根据标准曲线对样品洗脱液中的RCT含量进行定量计算。7. Quantitatively calculate the RCT content in the sample eluate according to the standard curve.
结果判定:标准对照孔的OD值随着RCT浓度的下降而升高,第12孔OD值应最高;将样品检测孔OD值与标准对照孔的OD值比较,若OD值相同则被检样品中的RCT含量与对应标准溶液的RCT浓度相同,检测结果如下:Result judgment: The OD value of the standard control well increases with the decrease of the RCT concentration, and the OD value of the 12th well should be the highest; compare the OD value of the sample detection well with the OD value of the standard control well, if the OD value is the same, the tested sample The RCT content in the solution is the same as the RCT concentration of the corresponding standard solution, and the test results are as follows:
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510071059 CN1687783A (en) | 2005-05-24 | 2005-05-24 | Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510071059 CN1687783A (en) | 2005-05-24 | 2005-05-24 | Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1687783A true CN1687783A (en) | 2005-10-26 |
Family
ID=35305825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510071059 Pending CN1687783A (en) | 2005-05-24 | 2005-05-24 | Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1687783A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101509923A (en) * | 2009-02-16 | 2009-08-19 | 安徽农业大学 | Diagnosis sheet for detecting antigen/antibody and method for making same |
CN100570323C (en) * | 2006-08-08 | 2009-12-16 | 中国农业科学院农业质量标准与检测技术研究所 | A ractopamine immunoaffinity column and its preparation method and application |
CN101241134B (en) * | 2008-01-18 | 2012-05-30 | 华南农业大学 | Enzyme-linked immunosorbent assay kit and method for detecting ractopamine residues |
CN101315379B (en) * | 2008-07-15 | 2012-08-08 | 天津九鼎生物工程有限公司 | Reagent kit for detecting Ractopamine and application thereof |
CN102778564A (en) * | 2012-05-31 | 2012-11-14 | 华中农业大学 | Monoclonal antibody, enzyme linked immunosorbent assay method and kit for detecting ractopamine |
CN103100237A (en) * | 2012-12-31 | 2013-05-15 | 南宁市蓝光生物技术有限公司 | Mini-type efficient ractopamine immunoaffinity purification enriching column preparation and application |
CN107192820A (en) * | 2016-11-28 | 2017-09-22 | 天津科技大学 | The preparation method of the immunoaffinity gel detection column of protein anabolic hormone in a kind of detection food |
-
2005
- 2005-05-24 CN CN 200510071059 patent/CN1687783A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100570323C (en) * | 2006-08-08 | 2009-12-16 | 中国农业科学院农业质量标准与检测技术研究所 | A ractopamine immunoaffinity column and its preparation method and application |
CN101241134B (en) * | 2008-01-18 | 2012-05-30 | 华南农业大学 | Enzyme-linked immunosorbent assay kit and method for detecting ractopamine residues |
CN101315379B (en) * | 2008-07-15 | 2012-08-08 | 天津九鼎生物工程有限公司 | Reagent kit for detecting Ractopamine and application thereof |
CN101509923A (en) * | 2009-02-16 | 2009-08-19 | 安徽农业大学 | Diagnosis sheet for detecting antigen/antibody and method for making same |
CN102778564A (en) * | 2012-05-31 | 2012-11-14 | 华中农业大学 | Monoclonal antibody, enzyme linked immunosorbent assay method and kit for detecting ractopamine |
CN102778564B (en) * | 2012-05-31 | 2014-06-04 | 华中农业大学 | Monoclonal antibody, enzyme linked immunosorbent assay method and kit for detecting ractopamine |
CN103100237A (en) * | 2012-12-31 | 2013-05-15 | 南宁市蓝光生物技术有限公司 | Mini-type efficient ractopamine immunoaffinity purification enriching column preparation and application |
CN103100237B (en) * | 2012-12-31 | 2015-12-02 | 南宁市蓝光生物技术有限公司 | Micro high efficiency Ractopamine immunoaffinity purification enriching column preparations and applicatio |
CN107192820A (en) * | 2016-11-28 | 2017-09-22 | 天津科技大学 | The preparation method of the immunoaffinity gel detection column of protein anabolic hormone in a kind of detection food |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1844926A (en) | ELISA kit for detecting Sudan red medicines and detection method thereof | |
CN101241134B (en) | Enzyme-linked immunosorbent assay kit and method for detecting ractopamine residues | |
CN1153908A (en) | Reagent kit and detection method of aflatoxins B1 | |
CN1811443A (en) | Method for detecting 19-nortestosterone and special enzyme-linked immune reagent kit thereof | |
CN1811436A (en) | Method for detecting Ennoxacin and its special enzyme-linked immune reagent kit | |
CN109374879B (en) | Detection kit for cow milk component doped in goat milk and goat milk powder and detection method thereof | |
CN1687783A (en) | Affinity chromatography-enzyme linked immunity test method for ractopamine and dedicated kit | |
CN107436351B (en) | Detection kit for reconstituted milk adulteration in fresh milk and detection method thereof | |
CN1150840A (en) | A method for detecting presence of mycobacterium species and kit and antibodies for use therein | |
CN101936984B (en) | Method and special chemical luminous immunoassay kit for detecting clenbuterol | |
CN1916591A (en) | Ractopamine column, preparation method and usage | |
CN1811440A (en) | Method for detecting Ivermectin and special enzyme-linked immune reagent kit thereof | |
CN1766630A (en) | An enzyme-linked immunosorbent assay kit for detecting ractopamine in food of animal origin | |
CN1766617A (en) | ELISA kit for detecting beta-stimulants and detection method thereof | |
CN1766631A (en) | An enzyme-linked immunosorbent assay kit for detecting sulfonamide drug residues in food of animal origin | |
CN1807402A (en) | Method for purifying alficetin and its special immune affinity chromatographic column | |
CN1766624A (en) | ELISA kit for detecting furazolidone metabolites and detection method thereof | |
CN100338467C (en) | Enzyme-linked immunological kit for detecting tetracycline drug | |
CN101561439A (en) | Nitrofurantoin residue enzyme-linked immunoassay kit | |
JP4170139B2 (en) | Method for detecting change in serum apolipoprotein A-II amount | |
CN1844927A (en) | ELISA kit for detecting fluoromethylquinoline and detection method thereof | |
CN1830546A (en) | Method and immunoaffinity chromatographic column for purifying albuterol and/or clenbuterol | |
CN1707266A (en) | A kind of ELISA kit for detecting clenbuterol | |
CN1696698A (en) | Affinity chromatography-enzyme-linked immunoassay method for PAT protein and its special kit | |
CN111909903B (en) | Zilpaterol monoclonal antibody hybridoma cell strain and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |